DP071 | QUALITY AND DURATION OF RESPONSES TO MOGAMULIZUMAB IN CUTANEOUS T-CELL LYMPHOMA: AN INSIGHT INTO DURABLE OUTCOMES

Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous T-cell lymphomas. In the phase 3 MAVORIC trial, mogamulizumab showed efficacy in patients who had received at least one systemic therapy, with objective responses in 28% of cases and a median progression-free-survival of...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	C. Mazzoni, A. Broccoli, L. Argnani, A. Pileri, B. Sordi, P. Fava, P. Quaglino, E. Pennese, T. Perrone, A. Bernardelli, M. Teoli, L. Flenghi, A. Ibatici, C. Massone, P.L. Zinzani
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Ferrata Storti Foundation 2025-09-01
Reeks:	Haematologica
Online toegang:	https://haematologica.org/article/view/12730
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!